Home » Newsletters » BioWorld Science

BioWorld Science

May 21, 2020

View Archived Issues

The world according to GARP

SGT-001 data support potential for treating Duchenne muscular dystrophy

Shorter telomere length tied to moderate to severe COPD

ViiV Healthcare patents new antivirals for HIV-1 infection

Topline phase I data and interim phase I/II results presented for Trappsol Cyclo in NPC1

CODA Biotherapeutics enters research collaboration with the FPRF

FDA approves IND application for phase III study of Octagam 10% in severe COVID-19 patients

Janssen Pharmaceutica discloses SGLT2 inhibitors

FDA clears IND application for FT-538

AiCuris identifies HBV capsid assembly inhibitors

MyoKardia synthesizes new cardiac myosin inhibitors

Targovax presents next-generation ONCOS virus, ONCOS-214

Novel mouse model for small cell carcinoma of bladder

Amygdala contains pain suppression circuit

Merck & Co. describes new SCN10A channel blockers

Antiviral Fc-conjugate CD-377 shows potent activity against influenza

CanSino initiates phase I trial of PCV13i vaccine

Administration of scAAV9.CLN8 shows promise for treating CLN8-driven Batten disease

Anavex receives Australian clearance for first-in-human study of ANAVEX 3-71

FDA clears Alethia's IND for phase II study of AB-16B5 in NSCLC

Topline phase IIb/III data reported for filgotinib in moderate to severely active ulcerative colitis

PDE2 plus PDE9 inhibition synergistically improves synaptic plasticity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...